A Study of Patients With Fabry Disease (US Specific)

NCT06906367 · clinicaltrials.gov ↗

RECRUITING

Status

450

Enrollment

INDUSTRY

Sponsor class

Conditions

Fabry Disease

Interventions

DRUG: migalastat HCl
DRUG: ERT

Sponsor

Amicus Therapeutics